Speak to the pharma team
01628 581 240
Speak to the healthcare team
01225 336 335
Speak to the clinical team
01628 581 240
Speak to the contract team
01225 336 335
Speak to us about Master Vendor
01225 336 335
Or send your enquiry via email and the best person to help will be in touch.
solutions@starmedical.co.uk
Founded in 1928 UCB is a market leader in the field of central nervous system disorders, allergy, immune and inflammatory diseases and oncology. UCB used to be a hybrid Pharma and chemicals accompany into a pure biopharmaceutical leader. UCB has headquarters in Belgium, UCB also has research sites in the UK.
UCB's products aim to "bring longer lives and healthier living to people all over the world." They make products that treat epilepsy, the effects of ageing on the brain, allergies and the many different types of cancer therapies.
UCB has recently merged with Schwarz Pharma.
Keppra is an anti-epileptic drug that is used to treat partial onset seizures in people with epilepsy, Keppra is also used to treat myoclonic seizures. Keppra is always used with other epilepsy medications. It has reached the one million patient years threshold. The equivalent of a culminated treatment of one million patients during a full year.
Nootropil's active ingredient is piracetam, Piracetam is a medicine used to treat certain types of movement disorder resulting from brain disease.
Xyzal tablets contain the active ingredient levocetivizine, which is a type of medicine called a non sedating antihistamine. It works by preventing the actions of histamine.
